Literatur
-
01
Block GA .
Raggi P .
Bellasi A .
et al .
Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients.
Kidney Int.
2007;
71 (5)
438-441
-
02
Block GA .
Spiegel DM .
Ehrlich J .
et al .
Effects of sevelamer and kalzium on coronary artery calcification in patients new to hemodialysis.
Kidney Int.
2005;
68 (4)
1815-1823
-
03
Braun J .
Oldendorf M .
Moshage W .
et al .
Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients.
Am J Kidney Dis.
1996;
27 (3)
394-401
-
04
Caglar K .
Yilmaz MI .
Saglam M .
et al .
Short-term treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients.
Clin J Am Soc Nephrol.
2008;
3 (1)
61-68
-
05
Celermajer DS .
Sorensen KE .
Gooch VM .
et al .
Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis.
Lancet.
1992;
340 (8828)
1111-1115
-
06
Chertow GM .
Burke SK .
Raggi P .
et al .
Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients.
Kidney Int.
2002;
62 (1)
245-252
-
07
Ferramosca E .
Burke S .
Chasan-Taber S .
et al .
Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients.
Am Heart J.
2005;
149
820-825
-
08
Fox CS .
Larson MG .
Keyes MJ .
et al .
Kidney function is inversely associated with coronary artery calcification in men and women free of cardiovascular disease: the Framingham Heart Study.
Kidney Int.
2004;
66
2017-2021
-
09
Giachelli CM .
Jono S .
Shioi A .
et al .
Vascular calcification and inorganic phosphate.
Kidney Dis.
2001;
38 (4 suppl 1)
34-37
-
10 Ketteler M et al. ASN 2005 (abstract).
-
11
London GM .
et al .
J Am Soc Nephrol.
2004;
15
1942-1953
-
12
Murshed M .
Harmey D .
Millán JL .
et al .
Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone.
Genes Dev.
2005;
19 (9)
1093-1104
-
13
Neunteufl T .
Heher S .
Katzenschlager R .
et al .
Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain.
Am J Cardiol.
2000;
86 (2)
207-210
-
14
Schäfer C .
Heiss A .
Schwarz A .
et al .
The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification.
J Clin Invest.
2003;
112
357-366
-
15 Schlieper G et al. Kongress für Nephrologie 2007; Mo-3-P05 (Poster).
-
16
Schlieper G .
Brandenburg V .
Djuric Z .
et al .
Korrelieren C-reaktives Protein und Verkalkungsinhibitoren bei Hämodialyse-Patienten mit kardiovaskulären Parametern und Risikofaktoren? .
Dtsch Med Wochenschr.
2007;
132 (36)
1820-1824
-
17 Schlieper G, Hristov M, Westenfeld R et al. Predictors of low circulating endothelial progenitor cell numbers in haemodialysis patients. Nephrol Dial Transplant 2008; im Druck.
-
18
Schurges L .
Shearer MJ .
Hamulyák K .
et al .
Effect of vitamin K intake on the stability of oral anticoagulant treatment: dose-response relationships in healthy subjects.
Blood.
2004;
104 (9)
2682-2689
-
19
Suki WN .
Zabaneh R .
Cangiano JL .
et al .
Effects of sevelamer and kalzium-based phosphate binders on mortality in hemodialysis patients. Kidney Int 2007.
Kidney Int.
2007;
72 (9)
1130-1137
01 Kidney Disease Outcomes Quality Initiative
02 Treat-to-Goal
03 Dialysis Clinical Outcomes Revisited
04 Renagel in New Dialysis Patients
